CSF-1R in Cancer: More than a Myeloid Cell Receptor.
CSF-1R
cancer cell signaling
cell migration
cell proliferation
chemoresistance
stemness
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
09 Jan 2024
09 Jan 2024
Historique:
received:
13
12
2023
revised:
04
01
2024
accepted:
05
01
2024
medline:
23
1
2024
pubmed:
23
1
2024
entrez:
23
1
2024
Statut:
epublish
Résumé
Colony-stimulating factor 1 receptor (CFS-1R) is a myeloid receptor with a crucial role in monocyte survival and differentiation. Its overexpression is associated with aggressive tumors characterized by an immunosuppressive microenvironment and poor prognosis. CSF-1R ligands, IL-34 and M-CSF, are produced by many cells in the tumor microenvironment (TME), suggesting a key role for the receptor in the crosstalk between tumor, immune and stromal cells in the TME. Recently, CSF-1R expression was reported in the cell membrane of the cancer cells of different solid tumors, capturing the interest of various research groups interested in investigating the role of this receptor in non-myeloid cells. This review summarizes the current data available on the expression and activity of CSF-1R in different tumor types. Notably, CSF-1R
Identifiants
pubmed: 38254773
pii: cancers16020282
doi: 10.3390/cancers16020282
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Mesothelioma Applied Research Foundation
ID : MARF-ERK5
Organisme : Italian Association for Cancer Research
ID : IG-15378, IG-23179